Pemetrexed-TL - analogs
Components: Pemetrexed |
|||||||||
Pharmgroups: Antimetabolites || Folic acid analogues |
|||||||||
| Prices in pharmacies: — Instructions Pemetrexed-TL | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Paracetamol ✘ (incl) Flumetasone ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | Dangerous 🔍 Pemetrexed | 407.7€ |
| ≈100% | Dangerous 🔍 Alimta | 447.2-480€ |
| ≈100% | Dangerous 🔍 Pemetrexed-nativ | — |
| ≈100% | Dangerous 🔍 Pemetrexed disodium | — |
| ≈100% | Dangerous 🔍 Pemetrexed J | — |
| ≈100% | Dangerous 🔍 Verotrexed | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 50% 2103.9€ Mekinist neutral [Trametinib]
- 45% — Erlotinib - native neutral [Erlotinib]
- 45% 9.4-25.8€ Vinelbine Negative 🔍 [Vinorelbine]
- 45% 838€ Tarceva neutral [Erlotinib]
- 41% 4-22.5€ Vinorelbine -Teva Negative 🔍 [Vinorelbine]
- 41% 46.5€ Maverex Negative 🔍 [Vinorelbine]
- 41% 15.5-57.5€ Cytuvin Negative 🔍 [Vinorelbine]
- 41% 32.3-50.9€ Navelbine Negative 🔍 [Vinorelbine]
- 41% — Erlotinib neutral [Erlotinib]
- 39% 2535.2€ Alecensa neutral [Alectinib]
- 37% 40€ Velbin Negative 🔍 [Vinorelbine]
- 37% — Vinorelbine Kelun-Kazpharm Negative 🔍 [Vinorelbine]
- 37% — Лорвиква Negative 🔍 [Lorlatinib]
- 36% — Tomudex Negative 🔍 [Raltitrexed]
- 35% — Vinorelbine Negative 🔍 [Vinorelbine]
- 35% 250-450€ Opdivo Negative 🔍 [Nivolumab]
- 34% — Tarlenib neutral [Erlotinib]
- 32% — Vincatera Negative 🔍 [Vinorelbine]
- 30% 29.8€ Imuron-vac neutral [Vaccinum for immunotherape cancer of vesica urinaria]
- 30% — Oncofage neutral [Proteine]
- 28% 5550€ Tagrisso neutral [Osimertinib]
- 28% — Осимертиниб neutral [Osimertinib]
- 28% 862.9€ Vargatef neutral [Nintedanib]
- 28% 1114€ Iressa neutral [Gefitinib]
- 28% — Zykadia neutral [Ceritinib]
- 28% — Gefitinib neutral [Gefitinib]
- 28% — Осимертиниба мезилат neutral [Osimertinib]
- 28% — Vinorelbine tartrate Negative 🔍 [Vinorelbine]
- 28% — Vinorelbine medac Negative 🔍 [Vinorelbine]
- 28% — Vinorelbine bitartrate Negative 🔍 [Vinorelbine]
- 28% 115€ Vidaza Negative 🔍 [Azacitidine]
- 28% — Vincarelbine Negative 🔍 [Vinorelbine]
- 26% 637.5-902.1€ Giotrif neutral [Afatinib]
- 26% — Эрлотиниб-тл neutral [Erlotinib]
- 25% — Пемброриа Negative 🔍 [Pembrolizumab]
- 24% — Gemcitabine Actavis Negative 🔍 [Gemcitabine]
- 24% 19.6€ Gemcitabine-Teva Negative 🔍 [Gemcitabine]
- 24% — Gemtaz Negative 🔍 [Gemcitabine]
- 24% — Гемцитабин-промомед Negative 🔍 [Gemcitabine]
- 24% 12.5-59.4€ Gemcitare Negative 🔍 [Gemcitabine]
- 24% 9-49€ Gemzar Negative 🔍 [Gemcitabine]
- 24% — Gemcex Negative 🔍 [Gemcitabine]
- 24% 6.8-32€ Cytogem Negative 🔍 [Gemcitabine]
- 24% — Gemcitabine Pliva Negative 🔍 [Gemcitabine]
- 24% — Гемцитабин - Келун - Казфарм Negative 🔍 [Gemcitabine]
- 24% 22.5€ Gemita Negative 🔍 [Gemcitabine]
- 24% 26.2-41.9€ Gemcitabine medac Negative 🔍 [Gemcitabine]
- 24% 3.5-16.8€ Gemcitabine-Ebewe Negative 🔍 [Gemcitabine]
- 24% — Gemcitabine hydrochloride Negative 🔍 [Gemcitabine]
- 24% 66.6€ Gemcitover Negative 🔍 [Gemcitabine]
Learn more about the selection of analogues
- The drug has «Pemetrexed-TL» 18 full analogs, the cheapest - Пемелан (76.2-377.7€); 51 analog by action, the most similar - Mekinist (2103.9€).
- Medical online service has selected the best substitutes for Pemetrexed-TL based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Pemetrexed-TL to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.